Cullinan Therapeutics, Inc.CGEMNASDAQ
LOADING
|||
Operating Income Contraction
Below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-196.92M
↓ 237% below average
Average (6y)
$-58.36M
Historical baseline
Range
High:$144.65M
Low:$-196.92M
CAGR
+54.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-196.92M | -3.1% |
| 2023 | $-191.09M | -232.1% |
| 2022 | $144.65M | +312.9% |
| 2021 | $-67.95M | -12.6% |
| 2020 | $-60.34M | -170.9% |
| 2019 | $-22.27M | -52.7% |
| 2018 | $-14.59M | - |